AR: Problems and pitfalls of transition from paediatric to adult renal care. Pediatr Nephrol 2005;20:113–117.
8Yeung E, Kay J, Roosevelt GE, Brandon M, Yetman AT: Lapse of care as a predictor for morbidity in adults with congenital heart disease. Int J Cardiol 2008;125:62–65.
9Feudtner C, Christakis DA, Connell FA: Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980–1997. Pediatrics 2000;106:205–209.
10Meadows AK, Bosco V, Tong E, Fernandes S, Saidi A: Transition and transfer from pediatric to adult care of young adults with complex congenital heart disease. Curr Cardiol Rep 2009;11:291–297.
11Blum RW: Transition to adult health care: setting the stage. J Adolesc Health 1995;17:3–5.
12Kennedy A, Sloman F, Douglass JA, Sawyer SM: Young people with chronic illness: the approach to transition. Intern Med J 2007;37:555–560.
13American Academy of Pediatrics; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine: A consensus statement on health care transitions for young adults with special health care needs. Pediatrics 2002;110:1304–1306.
14Cystic Fibrosis Foundation: Patient Registry Annual Data Report. Bethesda, Cystic Fibrosis Foundation, 2008.
15Dodge JA, Lewis PA, Stanton M, Wilsher J: Cystic fibrosis mortality and survival in the UK: 1947–2003. Eur Respir J 2007;29:522–526.
16Moons P, Meijboom FJ: Healthcare provision for adults with congenital heart disease in Europe: a review. Curr Opin Pediatr 2010;22:573–578.
17Hagell A: Building a picture of health from data. J Fam Health 2015;25:32–33.
18Prader A, Largo RH, Molinari L, Issler C: Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta 1989;52(suppl): 1–125.
19Godbout A, Tejedor I, Malivoir S, Polak M, Touraine P: Transition from pediatric to adult healthcare: assessment of specific needs of patients with chronic endocrine conditions. Horm Res Paediatr 2012;78:247–255.
20Courtillot C, Baudoin R, Du Souich T, Saatdjian L, Tejedor I, Pinto G, Léger J, Polak M, Golmard JL, Touraine P; Transition GHD Group: Monocentric study of 112 consecutive patients with childhood onset GH deficiency around and after transition. Eur J Endocrinol 2013;169:587–596.
21Malivoir S, Courtillot C, Bachelot A, Chakhtoura Z, Téjédor I, Touraine P: Therapeutic education programme for patients with chronic endocrine conditions: transition from paediatric to adult services (in French). Presse Méd 2016;45:e119–e129.
22Bachelot A, et al: Impact of pediatric to adult care transition on quality of life in patients with congenital adrenal hyperplasia diagnosed during childhood. Endocr Connect 2017;pii: EC-17-0094.
23Hokken-Koelega A, van der Lely AJ, Hauffa B, Häusler G, Johannsson G, Maghnie M, Argente J, DeSchepper J, Gleeson H, Gregory JW, Höybye C, Keleştimur F, Luger A, Müller HL, Neggers S, Popovic-Brkic V, Porcu E, Sävendahl L, Shalet S, Spiliotis B, Tauber M: Bridging the gap: metabolic and endocrine care of patients during transition. Endocr Connect 2016;5:R44–R54.
24Garvey KC, Markowitz JT, Laffel LMB: Transition to adult care for youth with type 1 diabetes. Curr Diab Rep 2012;12:533–541.
Philippe Touraine, MD, PhD
Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du
Développement des Pathologies Gynécologiques Rares, Institut E3M-ICAN, Hôpitaux
Universitaires Pitié-Salpêtrière Charles-Foix, Médecine Sorbonne Université
47–83, boulevard de l’Hôpital, FR–75651 Paris Cedex 13 (France)
E-Mail [email protected]
Michel Polak, MD, PhD
Pediatric Endocrinology, Gynecology and Diabetology, Centre de Référence des Pathologies
Gynécologiques Rares et des Maladies Endocriniennes Rares de la Croissance et du
Développement, Hôpital Universitaire Necker Enfants Malades, Université Paris Descartes
149, rue de Sèvres, FR–75015 Paris (France)
E-Mail [email protected]
General Concepts
Polak M, Touraine P (eds): Transition of Care: From Childhood to Adulthood in Endocrinology, Gynecology, and Diabetes. Endocr Dev. Basel, Karger, 2018, vol 33, pp 10–16 (DOI: 10.1159/000487522)
______________________
“Child-Adult” Transition – Adolescence: When Illness Appears…
Sabine Malivoira, b, d · Karinne Guenichec, e
aReference Centre for Rare Endocrine Growth Disorders, Hôpital Robert-Debré and Hôpital Pitié-Salpêtrière, bEcole des Psychologues Praticiens, and cReference Centre for Rare Endocrine and Gynaecological Disorders, Hôpital Universitaire Necker Enfants Malades, Paris, dHealth Education Laboratory, UFR SMBH, Paris 13 University, Bobigny, and eClinical Psychology and Psychopathology Laboratory, EA 4056, Paris Descartes University, Boulogne-Billancourt, France
______________________
Abstract
Considering the patient’s transition from child to adolescent to adult and its psychological aspects in endocrinology and diabetology, it is necessary to recall the child’s psycho-affective development when he enters adolescence. Indeed, adolescence appears paradigmatic of the “child-adult” transition; it is a specific and decisive psychic process which allows the child to become an adult, that is to say autonomous and subject to his desire. In our paper, we study the resonance of a chronic disease in young people; type 1 diabetes is chosen.
© 2018 S. Karger AG, Basel
Perhaps talking about the psychological aspects of patients monitored using endocrinology and diabetology who are embarking on the “child-adolescent-adult” transition principally means remembering that it is a matter of the psycho-emotional development of the child as they enter adolescence. We actually see adolescence as a paradigm of the child’s transition to adulthood, in so far as it is a required and necessary passage that the child has to go through to become an adult, i.e. independent and with their own free will. It also involves assessing what “being pubescent” means psychologically in order to consider